OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)

Completed · Phase 3

Conditions studied: Chronic Obstructive Pulmonary Disease, COPD

In brief

The purpose of this study is to determine whether roflumilast is effective in the treatment of exacerbations in patients with chronic obstructive pulmonary disease (COPD).

Key facts

Study ID
NCT00076089
Run by
AstraZeneca
People needed
1100
Starts
2003-12-01
Expected to finish
2005-12-01
Last updated by the study team
2016-12-02

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.